Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed
In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin
NCI Advisory Groups To Be Cut By One-Third
Graalman Objects To Criticism On Contract Competition
Abstracts Of Papers From Conference On Adjuvant Therapy
Trending Stories
- Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use
“Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”









